| abstract |
The present invention relates to a liquid preparation comprising an electrolyte compound and a montelukast or a pharmaceutically acceptable salt thereof as an active ingredient and a process for producing the same, wherein the montelukast or a pharmaceutically acceptable salt thereof is substantially dissolved Since it exists in a solution state, there is no time-dependent stability and dissolution decrease, and the bioavailability can be increased. In addition, the liquid preparation of the present invention is excellent in stability, taste and flavor, and can improve patients' compliance with medicines, and thus can be useful for treating patients such as asthma and allergic rhinitis. |